Kristina Leppälä’s blog text on stakeholder sensemaking and the future value of personalized medicine. How do organizations persuade stakeholders to invest in innovations whose value remains uncertain? This question sits at the heart of many healthcare innovations, particularly in the field of personalized medicine. Although advances in genomics, diagnostics, and data analytics create new opportunities […]